Cargando…

Esophageal cancer: Recent advances in screening, targeted therapy, and management

The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaur, Puja, Kim, Min P., Dunkin, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229783/
https://www.ncbi.nlm.nih.gov/pubmed/25395880
http://dx.doi.org/10.4103/1477-3163.143720
_version_ 1782344167820623872
author Gaur, Puja
Kim, Min P.
Dunkin, Brian J.
author_facet Gaur, Puja
Kim, Min P.
Dunkin, Brian J.
author_sort Gaur, Puja
collection PubMed
description The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor marker for surveillance purposes, ways to target esophageal cancer stem cells as well as circulating tumor cells, and developing minimally invasive protocols to treat early-stage disease. The goal of this chapter is to highlight some of the recent advances and ongoing research in the field of esophageal cancer.
format Online
Article
Text
id pubmed-4229783
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42297832014-11-13 Esophageal cancer: Recent advances in screening, targeted therapy, and management Gaur, Puja Kim, Min P. Dunkin, Brian J. J Carcinog Review Article The incidence of esophageal cancer remains on the rise worldwide and despite aggressive research in the field of gastrointestinal oncology, the survival remains poor. Much remains to be defined in esophageal cancer, including the development of an effective screening tool, identifying a good tumor marker for surveillance purposes, ways to target esophageal cancer stem cells as well as circulating tumor cells, and developing minimally invasive protocols to treat early-stage disease. The goal of this chapter is to highlight some of the recent advances and ongoing research in the field of esophageal cancer. Medknow Publications & Media Pvt Ltd 2014-10-30 /pmc/articles/PMC4229783/ /pubmed/25395880 http://dx.doi.org/10.4103/1477-3163.143720 Text en Copyright: © 2014 Gaur http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gaur, Puja
Kim, Min P.
Dunkin, Brian J.
Esophageal cancer: Recent advances in screening, targeted therapy, and management
title Esophageal cancer: Recent advances in screening, targeted therapy, and management
title_full Esophageal cancer: Recent advances in screening, targeted therapy, and management
title_fullStr Esophageal cancer: Recent advances in screening, targeted therapy, and management
title_full_unstemmed Esophageal cancer: Recent advances in screening, targeted therapy, and management
title_short Esophageal cancer: Recent advances in screening, targeted therapy, and management
title_sort esophageal cancer: recent advances in screening, targeted therapy, and management
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229783/
https://www.ncbi.nlm.nih.gov/pubmed/25395880
http://dx.doi.org/10.4103/1477-3163.143720
work_keys_str_mv AT gaurpuja esophagealcancerrecentadvancesinscreeningtargetedtherapyandmanagement
AT kimminp esophagealcancerrecentadvancesinscreeningtargetedtherapyandmanagement
AT dunkinbrianj esophagealcancerrecentadvancesinscreeningtargetedtherapyandmanagement